              |
BIOwulf's mission is to reshape the delivery of medicine. BIOwulf will re-define the relationship between therapeutics, diagnostics and treatment by delivering personalized medicine that incorporates patient-specific information from gene expression, metabolic indicators and therapeutic response. Our Company will use its unique ability to extract and enhance pertinent knowledge from the enormous amount of raw data being generated by current genomics and Proteomics efforts. Our proprietary technology will enable us to integrate heterogeneous information sources, including gene and protein expression data, traditional clinical data, and longitudinal patient data. BIOwulf will be a leading pioneer enabling the application of the life sciences in healthcare. The Company is focused on the application of Machine Learning for use in Bioinformatics, Imaging and Medical Diagnostics. Our efforts in Bioinformatics include the analysis of Genomic and Proteomic data to determine which groups of genes, sets of gene variants and promoter regions to elucidate the biological foundations of genotype phenotype relationships useful in creating patient specific diagnostic tests and treatments. In addition, we have development programs in MEMS based nanotechnology for application in Genomics and Proteomics. Combined with our advancement in the field of computer aided analytics, and domain specific expertise, BIOwulf will deliver a paradigm shift in personalized medicine. |